Ratna Kiran Bhavaraju-Sanka, MD

Associate Professor

John. H Doran, M.D, F.A.C.P, Endowed Chair in Peripheral Neuropathy

Diagnosis is not the end, but the beginning of practice. ~Martin H. Fischer As a Neuromuscular neurologists, Dr. Sanka would like to pursue options to better the condition of her patients with chronic diseases. Dr. Sanka’s research focus has been in the areas of Muscular dystrophy, Autoimmune and Idiopathic neuromuscular disorders like Peripheral Neuropathy, Myasthenia gravis, Myopathy and Small fiber neuropathy. During the course of her work as a clinician and Associate professor, she realized that practicing medicine involves more than treating patients, Sanka assumed the role of the Clinic director to lead our clinic and provide efficient timely care to our patients in the current health care settings. We are developing innovative methods to train and use advance practice providers to overcome the shortage of neurologists. Dr. Sanka realizes this is the beginning of her career but she is excited about the opportunities lying ahead and ready to face the challenges to become a better clinician, researcher and leader for our department and community.

Professional Background
Education
- 2004 - Internship - Internal Medicine - University of Illinois College of Medicine
- 1998 - BM BS - Medicine - Andhra Medical College, NTR University of Health Sciences
Training
- 2010 - Postdoctoral Fellowship - Research - University of North Carolina
- 2009 - Clinical Fellowship - Neuromuscular - University of North Carolina
- 2007 - Residency - Neurology - University of Illinois College of Medicine
- 2004 - Internship - Internal Medicine - University of Illinois College of Medicine
- 1999 - Internship - King George Hospital
Appointments
- 10/2018 - Chair and Chair - John. H Doran, M.D, F.A.C.P, Endowed Chair in Peripheral Neuropathy, Dept of Neurology, San Antonio,TX, Neurology, San Antonio
- 2/2015 - Clinic Director - University of Texas Health Science Center at San Antonio, Neurology, San Antonio
- 10/2010 - Attending Physician - University Health SystemSan Antonio
- 10/2010 - Assistant Professor - University of Texas Health Science Center at San Antonio (UTHSCSA), Neurology, San Antonio
Instruction & Training
- 7/2016 - Present, Neurology Core Clerkship, The University of Texas Health Science Center
- 9/2015 - Present, Neurology Research, The University of Texas Health Science Center
- 7/2015 - Present, Neurology Core Clerkship, The University of Texas Health Science Center
- 7/2014 - Present, Special Topic, The University of Texas Health Science Center
- 5/2014 - Present, Medicine, Behavior Society, The University of Texas Health Science Center
- 10/2010 - Present, Neurology Core Clerkship, The University of Texas Health Science Center
Research & Grants

Research profile

Grants

05/22-Present
Alexion Pharmaceuticals, “A Phase 2, Randomized, Double Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of ALXN2050 in Adult Participants with Generalized Myasthenia Gravis”
Principal Investigator

09/21-Present
A Phase 3, Randomized, Open-Label, Parallel-Group Study to Compare the Pharmacodynamics, Pharmacokinetics, Efficacy, Safety, Tolerability, and Immunogenicity of Multiple Subcutaneous Injections of Efgartigimod PH20 SC With Multiple Intravenous Infusions of Efgartigimod in Patients With Generalized Myasthenia Gravis
Principal Investigator

07/21-Present
Viela Bio / A Randomized, Double-Blind, Multicenter, Placebo Controlled Phase 3 Study with Open-Label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adults with Myasthenia Gravis
Principal Investigator

03/2020-Present
A Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Chronic Inflammatory Demyelinating Polyneuropathy.
Principal Investigator

01/2020-06/2021
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients With Generalized Myasthenia Gravis
Principal Investigator

03/2018 - 02/2021
Funding Agency: Amicus Therapeutics, Inc.
A Prospective Non-Interventional Study In Subjects With Late-Onset Pompe Disease Who Are Currently Being Treated With Enzyme Replacement Therapy
Co-Investigator

03/2018 - 02/2020
Funding Agency: UCB Biosciences Inc.
A Multicenter, Randomized, Investigator and Subject Blind, Placebo-Controlled, Treatment Sequence Study Evaluating The Safety, Tolerability, and Efficacy of UCB7665 In Subjects With Moderate To Severe Myasthenia Gravis
Co-Investigator

10/2017 - 09/2020
Funding Agency: PTC Therapeutics Inc
A Phase III, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Ataluren In Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
Co-Investigator

12/2012-11/2029
Funding Agency: GBS/CIDP FOUNDATION INTERNATIONAL
Title: International Guillain Barre Outcome Study (IGOS)
Principal Investigator
Service

Department

02/2015-Present UT Health Physicians MARC Neurology (Medical Director)
02/2015-Present Department UT Health Physicians Neurology Clinic (Clinician)

Global

12/2016-Present Manuscript Reviewer JAMA Internal Medicine (Reviewer)
01/2016-Present Cases for CME in AANEM Website (Peer Review Committee Member)
08/2014-Present Manuscript Reviewer Muscle & Nerve (Reviewer)
Publications
Clinical
Board Certifications
- 2016 - United Council of Neurological Specialties - Autonomic Disorders - United Council of Neurological Specialties - Autonomic Disorders
- 2011 - American Board of Psychiatry and Neurology/Neuromuscular Medicine - American Board of Psychiatry and Neurology
- 2008 - American Board of Psychiatry and Neurology - American Board of Psychiatry and Neurology

You are here

Ratna Kiran Bhavaraju-Sanka, MD

Professional Background

Education

Training

Appointments

Instruction & Training

Research & Grants

Grants

Service

Department

Global

Publications

Clinical

Board Certifications